Samtasu (tolvaptan sodium phosphate) / Otsuka  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Samtasu (tolvaptan sodium phosphate) / Otsuka
NCT03510663: Phase I Study of OPC-61815

Completed
1
48
Japan
OPC-61815 16mg, OPC-61815 32mg, Moxifloxacin, Placebos
Otsuka Pharmaceutical Co., Ltd.
Congestive Heart Failure
07/18
07/18
NCT04182958: A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects

Completed
1
8
Europe
(14C)-OPC-61815
Otsuka Pharmaceutical Co., Ltd.
Healthy Adult Male
12/19
12/19
NCT05439148: OPC-61815 in Healthy Chinese Male Subjects

Completed
1
18
RoW
OPC-61815 injection
Otsuka Beijing Research Institute
Healthy Adult Male
09/22
09/22

Download Options